Arterial and cardiac aging: Major shareholders in cardiovascular disease enterprises. Part III: Cellular and molecular clues to heart and arterial aging

Circulation

Volumn 107, Issue 3, 2003, Pages 490-497

  Lakatta, Edward G ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Aging; Calcium; Cardiovascular diseases; Endothelium; Remodeling

Indexed keywords

BETA ADRENERGIC RECEPTOR; CALCIUM CHANNEL; GELATINASE A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR SP1; TRANSFORMING GROWTH FACTOR BETA;

AGING; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CARDIOVASCULAR DISEASE; EXCITATION CONTRACTION COUPLING; INTIMA; MOLECULAR MECHANICS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE; STRESS; STRUCTURE ACTIVITY RELATION; TELOMERE;

ADAPTATION, PHYSIOLOGICAL; AGING; ANIMALS; AORTA; ARTERIAL OCCLUSIVE DISEASES; ARTERIES; ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; HEART; MICE; OXIDATIVE STRESS; RABBITS; RATS; RECEPTORS, ADRENERGIC, BETA; TUNICA INTIMA;

EID: 0037469206     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000048894.99865.02     Document Type: Review

References (83)

1. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a "set up" for vascular disease. Circulation. 2003;107:139-146.
2. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease Enterprises: part II: the aging heart in health: links to heart disease. Circulation. 2003;107:346-354.
3. Michel JB, Heudes D, Michel O, et al. Effect of chronic ANG I-converting enzyme inhibition on aging processes: II: large arteries. Am J Physiol. 1994;267:RI24-R135.
4. Li Z, Froehlich J, Galis ZS, et al. Increased expression of matrix metalloproteinase-2 in the thickened intima of aged rats. Hypertension. 1999;33:116-123.
5. Haudenschild CC, Prescott MF, Chobanian AV. Aortic endothelial and subendothelial cells in experimental hypertension and aging. Hypertension. 1981;3(3 Pt 2):1148-1153.
6. Asai K, Kudej RK, Shen YT, et al. Peripheral vascular endothelial dysfunction and apoptosis in old monkeys. Arterioscler Thromb Vasc Biol. 2000;20:1493-1499.
7. Wang M, Lakatta EG. In situ imbalance of matrix metalloproteinase-2 activators and inhibitors in age associated aortic remodeling. Hypertension. 2002;39:865-873.
8. Jenkins GM, Crow MT, Bilato C. et al. Increased expression of membrane-type matrix metalloproteinase and preferential localization of matrix metalloproteinase-2 to the neointima of balloon-injured rat carotid arteries. Circulation. 1998;97:82-90.
9. Galis ZS, Sukhova GK, Libby P. Microscopic localization of active proteases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue. FASEB J. 1995;9:974-980.
10. Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation. 1998;97:916-931.
11. Stemerman MB, Weinstein R, Rowe JW, et al. Vascular smooth muscle cell growth kinetics in vivo in aged rats. Proc Natl Acad Sci USA. 1982;79:3863-3866.
12. Hariri RJ, Alonso DR, Hajjar DP, et al. Aging and arteriosclerosis: I: development of myointimal hyperplasia after endothelial injury. J Exp Med. 1986;164:1171-1178.
13. Sata M, Saiura A, Kunisato A, et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med. 2002;8:403-409.
14. Cheng L, Mantile G, Pauly R, et al. Adenovirus-mediated gene transfer of the human tissue inhibitor of metalloproteinase-2 blocks vascular smooth muscle cell invasiveness in vitro and modulates neointimal development in vivo. Circulation. 1998;98:2195-2201.
15. Pauly RR, Passaniti A, Bilato C, et al. Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ Res. 1994;75:41-54.
16. Pauly RR, Passaniti A, Crow M, et al. Experimental models which mimic the differentiation and dedifferentiation of vascular cells. Circulation. 1992;86(suppl 3):III-68-III-73.
17. McCaffrey TA, Nicholson AC, Szabo PE, et al. Aging and arteriosclerosis: the increased proliferation of arterial smooth muscle cells isolated from old rats is associated with increased platelet-derived growth factor-like activity. J Exp Med. 1988;167:163-74.
18. Santiago FS, Lowe HC, Kavurma MM, et al. New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury. Nat Med. 1999;5:1264-1269.
19. McCaffrey TA, Falcone DJ. Evidence for an age-related dysfunction in the antiproliferative response to transforming growth factor-beta in vascular smooth muscle cells. Mol Biol Cell. 1993;4:315-322.
20. Takasaki I, Chobanian AV, Sarzani R, et al. Effect of hypertension on fibronectin expression in the rat aorta. J Biol Chem. 1990;265:21935-21939.
21. Crawford DC, Chobanian AV, Brecher P. Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat. Circ Res. 1994;74:727-739.
22. Challah M, Nadaud S, Philippe M, et al. Circulating and cellular markers of endothelial dysfunction with aging in rats. Am J Physiol. 1997;273(4 Pt 2):H1941-H1948.
23. Wang M, Takagi G, Asai K, et al. Altered matrix metalloprotease-2 regulation and tissue angiotensin and age-associated aortic remodeling in non-human primates. Arterioscler Thromb Vasc Biol. 2002;22:878-a. Available at http://atvb.ahajournals.org/cgi/content/full/22/5/878-a. Accessed December 4, 2002.
24. Orlandi A, Marcellini M, Spagnoli LG. Aging influences development and progression of early aortic atherosclerotic lesions in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol. 2000;20:1123-1136.
25. Morisaki N, Saito I, Tamura K, et al. New indices of ischemic heart disease and aging: studies on the serum levels of soluble intercellular adhesion molecule-1 (ICAM-1) and soluble vascular cell adhesion molecule-1 (VCAM-1) in patients with hypercholesterolemia and ischemic heart disease. Atherosclerosis. 1997;131:43-48.
26. Belmin J, Corman B, Merval R, et al. Age-related changes in endothelial permeability and distribution volume of albumin in rat aorta. Am J Physiol. 1993;264(3 Pt 2):H679-H685.
27. Cernadas MR, Sanchez de Miguel L, Garcia-Duran M, et al. Expression of constitutive and inducible nitric oxide synthases in the vascular wall of young and aging rats. Circ Res. 1998;83:279-286.
28. Hongo K, Nakagomi T, Kassell NF, et al. Effects of aging and hypertension on endothelium-dependent vascular relaxation in rat carotid artery. Stroke. 1988;19:892-897.
29. Van der Loo B, Labugger R, Skepper JN, et. al. Enhanced peroxynitrite formation is associated with vascular aging. J Exp Med. 2000;192:1731-1743.
30. Sherr C, DePinho R. Cellular senescence: mitotic clock or culture shock? Cell Biol. 2001;102:407-410.
31. Chang E, Harley CB. Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci U S A. 1995;92:11190-11194.
32. Aviv H, Khan MY, Skurnick J, et al. Age dependent aneuploidy and telomere length of the human vascular endothelium. Atherosclerosis. 2001;159:281-287.
33. Okuda K, Khan MY, Skurnick J, et al. Telomere attrition of the human abdominal aorta: relationships with age and atherosclerosis. Atherosclerosis. 2000;152:391-398.
34. Benetos A, Okuda K, Lajemi M, et al. Telomere length as an indicator of biological aging: the gender effect and relation with pulse pressure and pulse wave velocity. Hypertension. 2001;37:381-385.
35. Minamino T, Miyauchi H, Yoshida T, et al. Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation. 2002;105:1541-1544.
36. Rivard A, Fabre JE, Silver M, et al. Age-dependent impairment of angiogenesis. Circulation. 1999;99:111-120.
37. Reed MJ, Corsa AC, Kudravi SA, et al. A deficit in collagenase activity contributes to impaired migration of aged microvascular endothelial cells. J Cell Biochem. 2000;77:116-126.
38. Reed MJ, Corsa A, Pendergrass W, et al. Neovascularization in aged mice: delayed angiogenesis is coincident with decreased levels of transforming growth factor beta1 and type I collagen. Am J Pathol. 1998;152:113-123.
39. Rivard A, Berthou-Soulie L, Principe N, et al. Age-dependent defect in vascular endothelial growth factor expression is associated with reduced hypoxia-inducible factor 1 activity. J Biol Chem. 2000:275:29643-29647.
40. Treins C, Giorgetti-Peraldi S, Murdaca J, et al. Regulation of vascular endothelial growth factor expression by advanced glycation end products. J Biol Chem. 2001;276:43836-43841.
41. Chen J, Bridsky SV, Goligorsky DM, et al. Glycated collagen I induces premature senescence-like phenotypic changes in endothelial cells. Circ Res. 2002;90:1290-1298.
42. Salonen R, Nyssonen K, Porkkala-Sarataho E, et al. The Kuopio Atherosclerosis Prevention Study (KAPS): effect of pravastatin treatment on lipids, oxidation resistance of lipoproteins, and atherosclerotic progression. Am J Cardiol. 1995;76:34C-39C.
43. Woo KS, Chook P, Raitakari OT, et al. Westernization of Chinese adults and increased subclinical atherosclerosis. Arterioscler Thromb Vasc Biol. 1999;19:2487-2493.
44. Adams MR, Nakagomi A, Keech A, et al. Carotid intima-media thickness is only weakly correlated with the extent and severity of coronary artery disease. Circulation. 1995;92:2127-2134.
45. Homma S, Hirose N, Ishida H, et al. Carotid plaque and intima-media thickness assessed by b-mode ultrasonography in subjects ranging from young adults to centenarians. Stroke. 2001;32:830-835.
46. Clarkson TB. Nonhuman primate models of atherosclerosis. Lab Anim Sci. 1998;48:569-572.
47. Fraticelli A, Josephson R, Danziger R, et al. Morphological and contractile characteristics of rat cardiac myocytes from maturation to senescence. Am J Physiol. 1989;257:H259-H265.
48. Anversa P, Palackal T, Sonnenblick EH, et al. Myocyte cell loss and myocyte cellular hyperplasia in the hypertrophied aging rat heart. Circ Res. 1990;67:871-885.
49. Lakatta EG. Cardiovascular aging research: the next horizons. J Am Geriatr Soc. 1999;47:613-625.
50. Cigola E, Kastura J, Li B, et al. Angiotensin II activates programmed myocyte cell death in vitro. Exp Cell Res. 1997;231:363-371.
51. Younes A, Boluyt MO, O'Neill L, et al. Age-associated increase in rat ventricular ANP gene expression correlates with cardiac hypertrophy. Am J Physiol. 1995;38:H1003-H1008.
52. Caffrey JL, Boluyt MO, Younes A, et al. Aging, cardiac proenkephalin mRNA and enkephalin peptides in the Fisher 344 rat. J Mol Cell Cardiol. 1994;26:701-711.
53. Wei JY, Spurgeon HA, Lakatta EG. Excitation-contraction in rat myocardium: alterations with adult aging. Am J Physiol. 1984;246:H784-H791.
54. Orchard CH, Lakatta EG. Intracellular calcium transients and developed tensions in rat heart muscle: a mechanism for the negative interval-strength relationship. J Gen Physiol. 1985;86:637-651.
55. Josephson IR, Guia A, Stern MD, et al. Alterations in properties of L-type Ca channels in aging rat heart. J Mol Cell Cardiol. 2002;34:297-308.
56. Walker KE, Lakatta EG, Houser SR. Age associated changes in membrane currents in rat ventricular myocytes. Cardiovasc Res. 1993;27:1968-1977.
57. 2+ regulation. J Mol Cell Cardiol. 2002;34:641-648.
58. Froehlich JP, Lakatta EG, Beard E, et al. Studies of sarcoplasmic reticulum function and contraction duration in young and aged rat myocardium. J Mol Coll Cardiol. 1978;10:427-438.
59. Lakatta EG. Cardiovascular regulatory mechanisms in advanced age. Physiol Rev. 1993;73:413-465.
60. Koban MU, Moorman AFM, Holtz J, et al. Expressional analysis of the cardiac Na-Ca exchanger in rat development and senescence. Cardiovasc Res. 1998;37:405-423.
61. Spurgeon HA, Steinbach MF, Lakatta EG. Chronic exercise prevents characteristic age-related changes in rat cardiac contraction. Am J Physiol. 1983;244:H513-H518.
62. Brenner DA, Apstein CS, Saupe KW. Exercise training attenuates age-associated diastolic dysfunction in rats. Circulation. 2001;104:221-226.
63. Tate CA, Taffet GE, Hudson EK, et al. Enhanced calcium uptake of cardiac sarcoplasmic reticulum in exercise-trained old rats. Am J Physiol. 1990;258:H431-H435.
64. Schmidt U, del Monte F, Miyamoto MI, et al. Restoration of diastolic function in senescent rat hearts through adenoviral gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase. Circulation. 2000;101:790-796.
65. Long X, Boluyt MO, O'Neill L, et al. Myocardial retinoid X receptor, thyroid hormone receptor, and myosin heavy chain gene expression in the rat during adult aging. J Gerontol A Biol Sci Med Sci. 1999;54:B23-B27.
66. Spurgeon HA, Thorne PR, Yin FCP, et al. Increased dynamic stiffness of trabeculae carneae from senescent rats. Am J Physiol. 1977;232:H373-H380.
67. 2+ release in the heart. Cardiovasc Res. 1992;26:193-214.
68. Hano O, Bogdanov KY, Sakai M, et al. Reduced threshold for myocardial cell calcium intolerance in the rat heart with aging. Am J Physiol. 1995;269:H1607-H1612.
69. Lakatta EG, Sollott SJ, Pepe S. The old heart: operating on the edge. In: Bock G, Goode JA, eds. Ageing Vulnerability: Causes and Interventions. Novartis Foundation Symposium 235. New York, NY: John Wiley and Sons. Ltd; 2001:172-201.
70. Lim CC, Apstein CS, Colucci WS, et al. Impaired cell shortening and relengthening with increased pacing frequency are intrinsic to senescent mouse cardiomyocyte. J Mol Cell Cardiol. 2000;32:2075-2082.
71. Zhang SJ, Zhou YY, Xiao R-P, et al. Age-associated reduction in recovery of the equilibrium state of myocyte length during reduced interstimulus intervals at higher stimulation rates. Biophysical J. 2000;78(suppl 1):227A. Abstract.
72. 2+ activation of PDH. Am J Physiol. 1999;276:H149-H158.
73. Lucas D, Sweda L. Cardiac reperfusion injury, aging, lipid peroxidation, and mitochondrial dysfunction. Proc Natl Acad Sci USA. 1998;95:510-514.
74. Xiao R-P, Spurgeon HA, O'Connor F, et al. Age-associated changes in β-adrenergic modulation on rat cardiac excitation-contraction coupling. J Clin Invest. 1994;94:2051-2059.
75. 2-adrenoceptor responses without changes in inhibitory G proteins or receptor kinases. J Clin Invest. 1998;101:1273-1282.
76. Sakai M, Danziger RS, Staddon JM, et al. Decrease with senescence in the norepinephrine-induced phosphorylation of myofilament proteins in isolated rat cardiac myocytes. J Mol Cell Cardiol. 1989;21:1327-1336.
77. Yin FCP, Spurgeon HA, Weisfeldt ML, et al. MechanicaI properties of myocardium from hypertrophied rat hearts. A comparison between hypertrophy induced by senescence and by aortic banding. Circ Res. 1980;46:292-300.
78. Helenius M, Hänninen M, Lehtinen SK, et al. Aging-induced up-regulation of nuclear binding activities of oxidative stress responsive NF-κB transcription factor in mouse cardiac muscle. J Mol Cell Cardiol. 1996;28:487-498.
79. Takahashi T, Schunkert H, Isoyama S, et al. Age-related differences in the expression of proto-oncogene and contractile protein genes in response to pressure overload in the rat myocardium. J Clin Invest. 1992;89:939-946.
80. Shida M, Isoyama S. Effects of age on c-fos and c-myc gene expression in response to hemodynamic stress in isolated, perfused rat hearts. J Mol Cell Cardiol. 1993;25:1025-1035.
81. Nitta Y, Abe K, Aoki M, et al. Diminished heat shock protein 70 mRNA induction in aged rat hearts after ischemia. Am Physiol Soc. 1994;267(5 Pt 2):H1795-H1803.
82. Boluyt MO, Lakatta EG. Cardiovascular aging in health. In: RA Altschuld, RA Haworth, eds. Heart Metabolism in Failure. Vol 4B. Greenwich, Conn: JAI Press Inc; 1998:257-303.
83. Shunkert H, Weinberg E, Bruckschlegel G, et al. Alteration of growth responses in established cardiac pressure overload hypertrophy in rats with aortic banding. J Clin Invest. 1995;96:2768-2774.